Piccotti JR[au] - Search Results

Year	Number of Results
1995	1
1996	2
1997	3
1998	2
1999	3
2005	2
2006	1
2008	2
2009	1
2012	1
2021	2
2022	1

1

CC-90009: A Cereblon E3 Ligase Modulating Drug That Promotes Selective Degradation of GSPT1 for the Treatment of Acute Myeloid Leukemia.

Hansen JD, Correa M, Alexander M, Nagy M, Huang D, Sapienza J, Lu G, LeBrun LA, Cathers BE, Zhang W, Tang Y, Ammirante M, Narla RK, Piccotti JR, Pourdehnad M, Lopez-Girona A. Hansen JD, et al. Among authors: piccotti jr. J Med Chem. 2021 Feb 25;64(4):1835-1843. doi: 10.1021/acs.jmedchem.0c01489. Epub 2021 Feb 16. J Med Chem. 2021. PMID: 33591756

2

Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.

Collinge M, Burns-Naas LA, Chellman GJ, Kawabata TT, Komocsar WJ, Piccotti JR, Shenton J, Wierda D. Collinge M, et al. Among authors: piccotti jr. J Immunotoxicol. 2012 Apr-Jun;9(2):210-30. doi: 10.3109/1547691X.2012.661486. Epub 2012 Mar 19. J Immunotoxicol. 2012. PMID: 22428536 Review.

3

Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK. Piccotti JR, et al. Transplantation. 1997 Mar 15;63(5):619-24. doi: 10.1097/00007890-199703150-00001. Transplantation. 1997. PMID: 9075827 Review. No abstract available.

4

Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody.

Narla RK, Modi H, Bauer D, Abbasian M, Leisten J, Piccotti JR, Kopytek S, Eckelman BP, Deveraux Q, Timmer J, Zhu D, Wong L, Escoubet L, Raymon HK, Hariharan K. Narla RK, et al. Among authors: piccotti jr. Cancer Immunol Immunother. 2022 Feb;71(2):473-489. doi: 10.1007/s00262-021-03010-6. Epub 2021 Jul 10. Cancer Immunol Immunother. 2022. PMID: 34247273

5

Alloantigen-reactive Th1 development in IL-12-deficient mice.

Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, Bishop DK. Piccotti JR, et al. J Immunol. 1998 Feb 1;160(3):1132-8. J Immunol. 1998. PMID: 9570526 Free article.

6

T-cell-dependent antibody response: assay development in cynomolgus monkeys.

Piccotti JR, Alvey JD, Reindel JF, Guzman RE. Piccotti JR, et al. J Immunotoxicol. 2005 Oct 1;2(4):191-6. doi: 10.1080/15476910500362838. J Immunotoxicol. 2005. PMID: 18958673

7

Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.

Piccotti JR, Lebrec HN, Evans E, Herzyk DJ, Hastings KL, Burns-Naas LA, Gourley IS, Wierda D, Kawabata TT. Piccotti JR, et al. J Immunotoxicol. 2009 Mar;6(1):1-10. doi: 10.1080/15476910802656440. J Immunotoxicol. 2009. PMID: 19519157

8

Induction of apoptosis by cationic amphiphilic drugs amiodarone and imipramine.

Piccotti JR, LaGattuta MS, Knight SA, Gonzales AJ, Bleavins MR. Piccotti JR, et al. Drug Chem Toxicol. 2005;28(1):117-33. doi: 10.1081/dct-39743. Drug Chem Toxicol. 2005. PMID: 15720040

9

Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.

Piccotti JR, Kawabata TT. Piccotti JR, et al. J Immunotoxicol. 2008 Jul;5(3):271-7. doi: 10.1080/15376510802311961. J Immunotoxicol. 2008. PMID: 18830887

10

Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.

Piccotti JR, Knight SA, Gillhouse K, Lagattuta MS, Bleavins MR. Piccotti JR, et al. J Appl Toxicol. 2006 Jul-Aug;26(4):333-40. doi: 10.1002/jat.1145. J Appl Toxicol. 2006. PMID: 16705757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results